Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Optiscan Imaging Limited ( (AU:OIL) ) has issued an update.
Optiscan Imaging Ltd has successfully closed its fully underwritten pro-rata renounceable entitlement offer, raising approximately $17.75 million to support its strategic transformation into a medical device manufacturer and digital healthcare solution provider. The offer, which was strongly supported by shareholders, will enable Optiscan to issue new shares and continue its growth in the digital health market, enhancing its industry positioning and potentially benefiting stakeholders through improved healthcare outcomes.
More about Optiscan Imaging Limited
Optiscan Imaging Ltd is a commercial stage medical technology company specializing in digital pathology and precision surgery solutions. The company is known for its miniaturized digital endomicroscopes, which offer high-resolution imaging for live optical biopsies, enhancing cancer diagnosis and surgical treatment. Optiscan’s technology supports real-time insights during surgery and diagnostics, with applications extending to the digital health market, including robotic surgery.
Average Trading Volume: 131,503
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$87.71M
For a thorough assessment of OIL stock, go to TipRanks’ Stock Analysis page.